Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

High unmet medical need for therapies that can reduce the substantial treatment burden affecting millions of patients globallyCombined in-licensing and financing for a novel long-acting clinical ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

While many types of dermatitis can be managed at home without medical treatment, you should consult a healthcare provider if you have any type of dermatitis with the following characteristics: ...

To that end, GOLD guidelines for COPD recommend tailoring treatment based on risk of exacerbation and symptom severity as well as on patient preference, including cost, availability, and the user’s ...